Near-term anti-CD25 monoclonal antibody administration protects murine liver from ischemia-reperfusion injury due to reduced numbers of CD4+ T cells.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4154778)

Published in PLoS One on September 04, 2014

Authors

Jinghui Yang1, Xiaoyu Wang1, Shaohua Song1, Fang Liu1, Zhiren Fu1, Quanxing Wang2

Author Affiliations

1: Department of Organ Transplantation, Shanghai ChangZheng Hospital, Second Military Medical University, Shanghai, China.
2: National Key Laboratory of Medical Immunology, Second Military Medical University, Shanghai, China.

Articles cited by this

New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol (2009) 5.57

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant (2004) 4.04

Hepatic ischemia/reperfusion injury--a fresh look. Exp Mol Pathol (2003) 2.81

Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest (2001) 2.79

Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J Immunol (2012) 2.70

Inflammatory cells in ischemic acute renal failure. Kidney Int (2004) 2.20

Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol (2009) 2.18

CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest (1997) 2.15

Therapeutic targeting of the interleukin-6 receptor. Annu Rev Pharmacol Toxicol (2011) 1.76

Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression. Transplantation (2005) 1.66

Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation (2004) 1.58

Ischemia-reperfusion and immediate T cell responses. Cell Immunol (2007) 1.55

A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J Immunol (1999) 1.27

Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency. J Leukoc Biol (1996) 1.19

The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int (2002) 1.14

Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials. BMJ (2003) 1.12

CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology (2006) 1.12

The sterile immune response during hepatic ischemia/reperfusion. Cytokine Growth Factor Rev (2012) 1.09

Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models. World J Gastroenterol (2013) 1.07

Recipient T cells mediate reperfusion injury after lung transplantation in the rat. J Immunol (2003) 1.05

T-lymphocytes contribute to hepatic leukostasis and hypoxic stress induced by gut ischemia-reperfusion. Microcirculation (1999) 1.05

IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. J Am Soc Nephrol (2013) 1.01

Adoptive regulatory T-cell therapy preserves systemic immune homeostasis after cerebral ischemia. Stroke (2013) 0.96

Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning. J Immunol (2006) 0.96

Innate and adaptive effects of inflammasomes on T cell responses. Curr Opin Immunol (2013) 0.88

Selection of induction therapy in kidney transplantation. Transpl Int (2012) 0.88

In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells. Mol Ther (2005) 0.84

Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia. J Cell Mol Med (2014) 0.82

CD4 positive T helper cells contribute to retinal ganglion cell death in mouse model of ischemia reperfusion injury. Exp Eye Res (2013) 0.80

Induction immunosuppression in liver transplantation: a review. Transpl Int (2013) 0.80

Initial immunosuppression with or without basiliximab: a comparative study. Transplant Proc (2012) 0.79

Ischemic preconditioning in the liver is independent of regulatory T cell activity. PLoS One (2012) 0.79

Deletion of regulatory T cells supports the development of intestinal ischemia-reperfusion injuries. J Surg Res (2013) 0.78

Very early alloantigen-independent trafficking of lymphocytes during ischemic acute kidney injury. Kidney Int (2007) 0.77

Basiliximab induction in patients receiving tacrolimus-based immunosuppressive regimens. Int Urol Nephrol (2012) 0.76

Induction therapy with basiliximab and full HLA mismatch. Transplant Proc (2013) 0.76